アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

leadiant biosciences, inc. - amphotericin b (unii: 7xu7a7droe) (amphotericin b - unii:7xu7a7droe), dimyristoylphosphatidylcholine, dl- (unii: u86zgc74v5) (dimyristoylphosphatidylcholine, dl- - unii:u86zgc74v5), dimyristoylphosphatidylglycerol, dl- (unii: bi71wt9p3r) (dimyristoylphosphatidylglycerol, dl- - unii:bi71wt9p3r) - amphotericin b 5 mg in 1 ml - abelcet ® is indicated for the treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin b therapy. this is based on open-label treatment of patients judged by their physicians to be intolerant to or failing conventional amphotericin b therapy (see description of clinical studies). description of clinical studies fungal infections data from 473 patients were pooled from three open-label studies in which abelcet ® was provided for the treatment of patients with invasive fungal infections who were judged by their physicians to be refractory to or intolerant of conventional amphotericin b, or who had preexisting nephrotoxicity. results of these studies demonstrated effectiveness of abelcet ® in the treatment of invasive fungal infections as a second line therapy. patients were defined by their individual physician as being refractory to or failing conventional amphotericin b therapy based on overall clinical judgement after receiving a minimu

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - lamivudine, quantity: 150 mg; zidovudine, quantity: 300 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; propylene glycol; magnesium stearate; sodium starch glycollate type a; titanium dioxide; hypromellose - lamivudine and zidovudine combination tablet is indicated for use alone or in combination with other antiretroviral therapies in the treatment of hiv infection.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - fluconazole, quantity: 150 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; magnesium stearate; lactose monohydrate; maize starch; silicon dioxide; titanium dioxide; potable water; gelatin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - for vaginal candidiasis

ヨルダン - 英語 - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - caspofungin 50 mg - 50 mg

フィリピン - 英語 - FDA (Food And Drug Administration)

n/a; importer: ambica international corporation; distributor: ambica international corporation - amphotericin-b - lyophilized powder for injection for i.v - 50 mg

タンザニア - 英語 - Tanzania Medicinces & Medical Devices Authority

bharat serums and vaccines limited, india - amphotericin b - lyophilized injection - 50 mg

インド - 英語 - Central Drugs Standard Control Organization

ranbaxy - amphotericin-b - 650mg - 50mg

フィリピン - 英語 - FDA (Food And Drug Administration)

srs pharmaceuticals phils., inc.; distributor: philcare pharma, inc. - amphotericin b - lyophilized powder for injection (iv) - 50mg

フィリピン - 英語 - FDA (Food And Drug Administration)

skingen biotech, inc; distributor: endure medical, inc. - amphotericin b - lyophilized powder for injection (iv) - 50 mg

フィリピン - 英語 - FDA (Food And Drug Administration)

stallion laboratories pvt. ltd; importer: ambica international corporation; distributor: ambica international corporation - amphotericin b - lyophilized powder for iv infusion - 50 mg